Post Leonard Einsider trades
In SEC Form 4 filings, Post Leonard E is listed as Director of CG Oncology, Inc. (CGON). In the last 90 days, Post Leonard E sold $135K of CG Oncology, Inc. (CGON) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CGONCG Oncology, Inc. | Director | 7 | Oct 19 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-17
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CGONCG Oncology, Inc. | Oct 15 | Oct 19 | M | 1,000 | $0.60 | $600 | 1,000 | Yes | Form 4 |
| CGONCG Oncology, Inc. | Oct 15 | Oct 19 | S | 500 | $61.65 | Sale −$30,825 | 500 | Yes | Form 4 |
| CGONCG Oncology, Inc. | Oct 15 | Oct 19 | S | 500 | $62.48 | Sale −$31,240 | not reported | Yes | Form 4 |
| CGONCG Oncology, Inc. | Oct 15 | Oct 19 | M · derivative | 1,000 | $0.60 | $600 | 102,077 | Yes | Form 4 |
| CGONCG Oncology, Inc. | Sep 15 | Sep 17 | M | 1,000 | $0.60 | $600 | 1,000 | Yes | Form 4 |
| CGONCG Oncology, Inc. | Sep 15 | Sep 17 | S | 1,000 | $72.98 | Sale −$72,980 | not reported | Yes | Form 4 |
| CGONCG Oncology, Inc. | Sep 15 | Sep 17 | M · derivative | 1,000 | $0.60 | $600 | 103,077 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.